# This Study Tests How Different Doses of BI 690517 Are Taken up in the Body of Healthy Men. The Study Also Looks at How Food Influences the Amount of BI 690517 in the Blood

> **NCT03100916** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 72 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** BI 690517
- **DRUG:** Placebo
- **DRUG:** BI 690517 (Reference)
- **DRUG:** BI 690517

## Key facts

- **NCT ID:** NCT03100916
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-05
- **Primary completion:** 2017-11-24
- **Final completion:** 2017-11-24
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2024-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03100916

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03100916, "This Study Tests How Different Doses of BI 690517 Are Taken up in the Body of Healthy Men. The Study Also Looks at How Food Influences the Amount of BI 690517 in the Blood". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03100916. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*